Drugs / 0.9% sodium chloride
0.9% sodium chloride
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00423722 Comparator | Jan 2007 → May 2013 | cancer of unknown primary site | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 0.9% sodium chloride | “1,000 ml of normal saline (0.9% sodium chloride) parenterally over 4 hours daily” NCT00423722 ↗ |
| Known as | normal saline | “Participants in Group 1 will receive normal saline (salt water) once a day.” NCT00423722 ↗ |
| Known as | Saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00423722 ↗ |
| Known as | salt water | “Participants in Group 1 will receive normal saline (salt water) once a day.” NCT00423722 ↗ |
| Route | Intravenous | “saline through a catheter in a vein” NCT00423722 ↗ |